Spotlight -

B + L Dry Eye Series|

Transforming Glaucoma Management|

Zeiss Clinical Cases

Viewing

|Articles|January 16, 2013

Intracameral antibiotic prophylaxis

New product approved to prevent postoperative endophthalmitis following cataract surgery

Newsletter

Don’t miss out—get OT Europe updates delivered straight to your inbox.

Related Content

Real-World Outcomes of a Spiral Optic IOL Compared with a Diffractive Trifocal

ByJames Myerscough, MD

August 1st 2026

Necessity-Driven Innovation - A Personal Journey Toward Efficient and Controlled 27-Gauge Vitrectomy

ByMitrofanis Pavlidis, MD, PhD

August 1st 2026

Staying at the top: Optimizing clinical care and practice efficiency with multimodal Triton imaging

Early Clinical Impressions of the Triton2 and IMAGEnet7® Understanding the Value of Swept-Source OCT Combined with High Quality Colour Fundus Imaging

April 14th 2026

EYLEA 8mg in RVO: QUASAR clinical perspectives video

March 3rd 2026

EYLEA 8mg in RVO: snapshot of the 64-week QUASAR data

March 3rd 2026

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Treatment Optimization in the Evolving Anti-VEGF Era

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD